---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-042528"
form_type: "8-K/A"
ticker: "PMHS"
cik: "0001265521"
company_name: "Polomar Health Services, Inc."
filed_at: "2024-10-25T23:59:59+00:00"
generated_at: "2026-05-30T09:59:13.045721+00:00"
event_type: "m_and_a"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Polomar Health Services completes acquisition of Polomar Specialty Pharmacy, files amended 8-K with financials

## Summary
- Polomar Health Services acquired 100% of Polomar Specialty Pharmacy on September 30, 2024 in exchange for common stock.
- Audited financials show $41,844 revenue and $171,497 net loss from inception (April 26, 2023) to December 31, 2023.
- Unaudited interim statements for six months ended June 30, 2024 show accumulated deficit of $433,567 and going concern uncertainty.
- Short-term debt due to related parties surged from $30,507 (Dec 2023) to $454,288 (June 2024).
- Financial statements include a material weakness in liquidity; cash was only $8,564 as of Dec 2023 and $19,563 as of June 2024.

## SEC filing metadata
- accession: 0001493152-24-042528
- form_type: 8-K/A
- ticker: PMHS
- cik: 0001265521
- company_name: Polomar Health Services, Inc.
- filed_at: 2024-10-25T23:59:59+00:00
- event_type: m_and_a
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 9.01, 2.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1265521/000149315224042528/0001493152-24-042528-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1265521/000149315224042528/form8-ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-042528
- JSON: https://secwatch.observer/filing/0001493152-24-042528.json
- Plain text: https://secwatch.observer/filing/0001493152-24-042528.txt

## Key facts
- M&A Transactions
  Polomar Health Services, Inc. completed an acquisition involving Polomar Specialty Pharmacy, LLC (closed 2024-09-30).
  - Action: acquisition
  - Counterparty: Polomar Specialty Pharmacy, LLC
  - Closing: 2024-09-30
  source text: On September 30, 2024, the Company completed its acquisition of Polomar Specialty Pharmacy, LLC, a Florida limited liability company ("Polomar"), whereby, among other things, the Company acquired 100% of Polomar in exchange for the issuance of shares of the Company’s common stock, and Polomar became the wholly-owned subsidiary of the Company (the "Acquisition").
  evidence_url: https://www.sec.gov/Archives/edgar/data/1265521/000149315224042528/0001493152-24-042528-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.